SCHEMBL7489474

SCHEMBL7489474

CCOC(=O)Cn1c(=O)c(=O)[nH]c2ccc(NC(C)=O)cc21

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 1/20 0.56
MMP13 P45452 1/20 0.48
GRIA1 P42261 3/20 0.48
GRIA2 P42262 3/20 0.48
GRIA3 P42263 3/20 0.48
GRIA4 P48058 3/20 0.48
PSMB8 P28062 1/20 0.46
GRIN2D O15399 1/20 0.44
GRIN3B O60391 1/20 0.44
GRIN1 Q05586 1/20 0.44
GRIN2A Q12879 1/20 0.44
GRIN2B Q13224 1/20 0.44
GRIN2C Q14957 1/20 0.44
GRIN3A Q8TCU5 1/20 0.44
ERCC1 P07992 2/20 0.43
FEN1 P39748 2/20 0.43
ERCC4 Q92889 2/20 0.43
DNASE1 P24855 1/20 0.43
ALDH1A1 P00352 3/20 0.42
HPGD P15428 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8609111 0.85 PSMB8 (0.53) ADORA3MMP13GRIA1GRIA2GRIA3
SCHEMBL7477922 0.82 ADORA3 (0.52) ADORA3GRIA1GRIA2GRIA3GRIA4
SCHEMBL7811625 0.81 GRIA1 (0.53) GRIA1GRIA2GRIA3GRIA4GRIN2D
SCHEMBL8609538 0.80 PSMB8 (0.48) ADORA3MMP13GRIA1GRIA2GRIA3
SCHEMBL8613842 0.79 PSMB8 (0.50) ADORA3MMP13GRIA1GRIA2GRIA3
SCHEMBL9092206 0.78 GRIA1 (0.58) GRIA1GRIA2GRIA3GRIA4GRIN2D
SCHEMBL7809114 0.76 GRIA1 (0.49) GRIA1GRIA2GRIA3GRIA4GRIN2D
SCHEMBL8191455 0.74 GRIA1 (0.53) GRIA1GRIA2GRIA3GRIA4GRIN2D
SCHEMBL9094909 0.74 GRIA1 (0.51) GRIA1GRIA2GRIA3GRIA4GRIN2D
SCHEMBL7476480 0.74 ADORA3 (0.53) ADORA3GRIA1GRIA2GRIA3GRIA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0799224-B1 QUINOXALINES AND DRUGS PREPARED THEREFROM BASF AG (DE) 2002-04-17 EP disclosed
US-5852017-A 2,3(1H,4H)-quinoxalinediones BASF AKTIENGESELLSCHAFT (DE) 1998-12-22 US disclosed
US-5849743-A Quinoxalines and drugs prepared therefrom BASF AKTIENGESELLSCHAFT (DE) 1998-12-15 US disclosed
EP-0572852-B1 Quinoxalin-2,3(1H,4H)-diones used as medicine BASF AG (DE) 1998-10-21 EP disclosed
US-5714489-A 2,3(1H,4H)quinoxalinedione BASF AKTIENGESELLSCHAFT (DE) 1998-02-03 US disclosed
WO-1996019476-A1 NOVEL QUINOXALINES AND DRUGS PREPARED THEREFROM BASF AKTIENGESELLSCHAFT (DE) 1996-06-27 WO disclosed
EP-0572852-A1 Quinoxalin-2,3(1H,4H)-diones used as medicine BASF Aktiengesellschaft (DE) 1993-12-08 EP disclosed